Právní předpis byl sestaven k datu 15.06.2025.
Zobrazené znění právního předpisu je účinné od 01.10.2015.
Nařízení vlády, kterým se mění nařízení vlády č. 463/2013 Sb., o seznamech návykových látek
243/2015 Sb.
Účinnost Čl. III
243
XXXXXXXX XXXXX
xx xxx 14. září 2015,
kterým xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx xxxxx §44c xxxx. 1 xxxxxx č. 167/1998 Sb., x xxxxxxxxxx látkách x x xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:
Xx. I
Příloha x. 4 x nařízení xxxxx č. 463/2013 Sb., o xxxxxxxxx návykových xxxxx, xxx:
"Xxxxxxx x. 4 x xxxxxxxx vlády x. 463/2013 Xx.
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx název xxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx IUPAC |
Poznámka |
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyclohexyl)]methyl}benzamid |
||
|
AM-2201 |
[1-(5-fluorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon |
||
|
5-AP1 |
5-(2-aminopropyl)indol |
||
|
APINACA |
N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid |
||
|
bk-PMA |
2-amino-1-(4-methoxyfenyl)propan-1-on |
||
|
bk-PMMA |
1-(4-methoxyfenyl)-2-(methylamino)propan-1-on |
||
|
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
||
|
Brolamfetamin |
DOB |
(2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin |
|
|
Bromo-Dragonfly |
1-(8-brombenzo[1,2b:4,5-b´]difuran-4-yl)propan-2-amin |
||
|
Butylon |
2-(methylamino)-1-[3,4-(methylendioxy)fenyl)]butan-1-on |
||
|
Joddimethoxyfenethylamin |
2C-I |
(4-jod-2,5-dimethoxyfenethyl)amin |
|
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
||
|
Dimethoxyethylthiofenethylamin |
2C-T-2 |
[4-(ethylsulfanyl)-2,5-dimethoxyfenethyl]amin |
|
|
Dimethoxypropylthiofenethylamin |
2C-T-7 |
[2,5-dimethoxy-4-(propylsuIfanyl)fenethyl]amin |
|
|
CP-47,497 |
2-[(1R,3S)-3-hydroxycyklohexyl]-5-(2-methyloktan-2-yl)fenol |
||
|
CRA-13 |
(naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon |
||
|
DBZP |
1,4-dibenzylpiperazin |
||
|
Dielhyltryptamin |
DET |
N,N-diethyl-N-[2-(indol-3-yl)ethyl]amin |
|
|
Dimethoxyamfetamin |
DMA |
(2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin |
|
|
4,4'-DMAR |
4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin |
||
|
Dimethylheptyltetrahydrokanabinol |
DMHP |
3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c] xxxxxxx-1-xx |
|
|
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX |
X[2-(xxxxx-3-xx (ethyl]-N,N-dimethylamin |
|
|
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
||
|
Dimethoxyethylamfetamin |
DOET |
(2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin |
|
|
DOl |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
||
|
Eticyklidin |
PCE |
N-ethyl-1-fenylcyklohexylamin |
|
|
Etryptamin |
3-(2-aminobutyl)indol |
||
|
4-FA |
1-(4-fluorfenyl)propan-2-amin |
||
|
5F-AKB48 |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid |
||
|
Flefedron |
1-(4-fluorfenyl)-2-(methylamino)propan-1-on |
||
|
4-FMA |
1-(4-fluorfenyl)-N-methylpropan-2-amin |
||
|
3-FMC |
1-(3-fluorfenyl)-2-(methylamino)propan-1-on |
||
|
5FUR-144 |
[1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon |
||
|
251-NBOMe |
2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
||
|
JWH-018 |
(naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
|
JWH-081 |
(4-methoxynaftalen-1-yl)(1 -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-x)xxxxxxxx |
||
|
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
4-Xxxxxxxxxxxx |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
||
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
||
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
||
|
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-XXX |
2-(xxxxxxxxxxx(-1-(3-xxxxxXxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
||
|
xxxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
||
|
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
||
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)-xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxXxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxx-xxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x, 10b-dimethyl-4,10-dioxododekahydro-1H-benzo[f]isochromen-7-karboxylát |
||
|
Dimethoxymetamfetamin |
STP, DOM |
(2RS)-1-(2,5-dimethoxy-4-methylfenyl]propan-2-amin |
|
|
Tenamfetamin |
MDA |
(2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
|
Tenocyklidin |
TCP |
1-[1-(2-thienyl)cyklohexyl]piperidin |
|
|
TFMPP |
1-[3-(trifluormethyl)fenyl]piperazin |
||
|
Tetrahydrokanabinol |
THC |
Δ6a(10a)-,Δ6a(7)-,Δ7-,Δ8-,Δ10-,Δ9(11)-tetrahydrokanabinoly x jejich xxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx látek, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx v xxxxx xxxxxxx xx xxxxx xxxxxxxxx, kdy xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx podle zvláštního xxxxxxxxxx xxxxxxxx a xxxx xxxxxxxxxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx xx všech xxxxxxxxx, xxx mohou xxxxxxxxx.".
Xx. II
Toto xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES xx xxx 22. června 1998 x xxxxxxx xxx poskytování informací x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx, x platném znění.
Xx. XXX
Xxxxxxxx
Xxxx nařízení xxxxxx účinnosti dnem 1. xxxxx 2015.
Předseda xxxxx:
Xxx. Xxxxxxx x. x.
&xxxx;Xxxxxxx zdravotnictví:
MUDr. Xxxxxxx, XXX, v. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 243/2015 Sb. xxxxx xxxxxxxxx xxxx 1.10.2015.
Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx xxxxx shora uvedeného xxxxxxxx předpisu.